hypertension
Conditions
Interventions
None listed
Sponsors
National Hospital Organization
Cooperative research group for PHAS-J Study of National Hospital Organization
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Hypertensive patients in the outpatient clinic and hospital, who full-fill the following 1) or 2) criteria: 1)treated hypertensive patients 2)untreated hypertensive patients with systolic blood pressure higher than 140mmHg or diastolic blood pressure higher than 90mmHg according to the guideline of the Japan Society of Hypertension.
Exclusion criteria
Exclusion criteria: 1)pregnant patients 2)patients taking diuretics or aldosterone antagonist 3)patients with the following diseases: (1)secondary hypertension (renal hypertension,renovascular hypertension, primary aldosteronism, Cushing's syndrome, pheochromocytoma, iatrogenic diseases etc) (2)patients whom the attending doctors decides not suitable for the entry because of the unstable stage of the following complications: coronary diseases, arrhythmia, severe valvular diseases, cerebrovascular diseases, acute and chronic renal failure (serum Cr higher than 3mg/dl), acute and chronic liver diseases (3)orthostatic hypotension 4) Patients whom the attending doctor decides not suitable for the entry of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of primary aldosteronism in patients with hypertension in Japan | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are to establish the importance of investigating the cause of hypertension in clinical practice and to spread the standard medical practice specific to the cause of hypertension. | — |
Countries
Japan
Contacts
Public ContactMitsuhide Naruse
National Hospital Organization, Kyoto Medical Center Department of Endocrinology, Clinical Research Institute for Endocrine and Metabolic Diseases
Outcome results
None listed